ArticleCureus2025
The Silent Bleeder: A Case of Recurrent Hemorrhage From a Dieulafoy's Lesion.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dieulafoy's lesion is a rare but potentially life-threatening cause of gastrointestinal (GI) bleeding. We report the case of a 75-year-old woman with a history of transient ischemic attack (TIA), hypertension, chronic obstructive pulmonary disease (COPD), and non-small cell lung cancer (NSCLC), who presented with dizziness, nausea, and abdominal pain. Initial evaluations revealed progressive anemia, though no source of bleeding was identified on imaging, nor were there external signs of bleeding. Endoscopy later confirmed an actively bleeding Dieulafoy's lesion, which was successfully treated with hemoclips. This case highlights the diagnostic challenges of Dieulafoy's lesion due to its intermittent bleeding and nonspecific presentation. Endoscopic intervention remains the first-line treatment, and early recognition is crucial to prevent life-threatening complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.